이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Coral Laboratories 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Girish Dhameja

최고 경영자

₹2.8m

총 보상

CEO 급여 비율	98.0%
CEO 임기	7.2yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	6.2yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Girish Dhameja 의 보수는 Coral Laboratories 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	₹158m
Dec 31 2023	n/a	n/a	₹91m
Sep 30 2023	n/a	n/a	₹78m
Jun 30 2023	n/a	n/a	₹67m
Mar 31 2023	₹3m	₹3m	₹64m
Dec 31 2022	n/a	n/a	₹99m
Sep 30 2022	n/a	n/a	₹93m
Jun 30 2022	n/a	n/a	₹48m
Mar 31 2022	₹3m	₹3m	₹90m
Dec 31 2021	n/a	n/a	₹82m
Sep 30 2021	n/a	n/a	₹126m
Jun 30 2021	n/a	n/a	₹141m
Mar 31 2021	₹3m	₹3m	₹136m
Dec 31 2020	n/a	n/a	₹153m
Sep 30 2020	n/a	n/a	₹129m
Jun 30 2020	n/a	n/a	₹120m
Mar 31 2020	₹2m	₹2m	₹71m
Dec 31 2019	n/a	n/a	₹25m
Sep 30 2019	n/a	n/a	₹33m
Jun 30 2019	n/a	n/a	₹70m
Mar 31 2019	₹2m	₹2m	₹102m
Dec 31 2018	n/a	n/a	₹144m
Sep 30 2018	n/a	n/a	₹134m
Jun 30 2018	n/a	n/a	₹141m
Mar 31 2018	₹2m	₹2m	₹124m

보상 대 시장: Girish 의 총 보상 ($USD 33.69K )은 Indian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 38.49K ).

보상과 수익: Girish 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Girish Dhameja (43 yo)

7.2yrs

테뉴어

₹2,813,435

보상

Mr. Girish Madanlal Dhameja has been an Whole-Time Director of Coral Laboratories Limited since May 26, 2017. His present profile includes handling export enquiry finalization and execution of order, busin...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Girish Dhameja	Whole-Time Director	7.2yrs	₹2.81m	데이터 없음
Sushma Kadkade	CFO & Non-Executive Director	7.2yrs	₹1.26m	데이터 없음
Sheela Kamdar	Non-Executive Independent Director	9.9yrs	₹43.00k	데이터 없음
Saurabh Shah	Independent Director	5.2yrs	₹15.00k	데이터 없음
Malay Doshi	Independent Director	3.2yrs	데이터 없음	데이터 없음
Rajendrasinh Rana	Non-Executive Director	2.8yrs	데이터 없음	데이터 없음

6.2yrs

평균 재임 기간

45.5yo

평균 연령

경험이 풍부한 이사회: 524506 의 이사회는 경험(평균 재직 기간 6.1 년)으로 간주됩니다.

Coral Laboratories 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Coral Laboratories Limited Announces Resignation of Ruchi Pipara as Company Secretary and Compliance Officer, with Effect from July 13, 2024

Coral Laboratories Limited Appoints Ruchi Pipara as Company Secretary, Compliance Officer and Key Managerial Personnel

Coral Laboratories Limited Announces Resignation of Shifa Memon as Company Secretary, Compliance Officer and Key Managerial Personnel

Coral Laboratories Limited Appoints Shifa Memon as Company Secretary and Compliance Officer, with Effect from March 9, 2024

Coral Laboratories Limited, Annual General Meeting, Aug 11, 2023

Coral Laboratories Limited, Annual General Meeting, Sep 29, 2022

Recent updates

Coral Laboratories Limited Announces Resignation of Ruchi Pipara as Company Secretary and Compliance Officer, with Effect from July 13, 2024

Investor sentiment improves as stock rises 19%

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Coral Laboratories Limited to Report Q4, 2024 Results on May 23, 2024

Coral Laboratories Limited Appoints Ruchi Pipara as Company Secretary, Compliance Officer and Key Managerial Personnel

Coral Laboratories Limited Announces Resignation of Shifa Memon as Company Secretary, Compliance Officer and Key Managerial Personnel

Coral Laboratories Limited Appoints Shifa Memon as Company Secretary and Compliance Officer, with Effect from March 9, 2024

Investor sentiment improves as stock rises 16%

Now 20% overvalued

Third quarter 2024 earnings released: EPS: ₹6.04 (vs ₹2.40 in 3Q 2023)

Coral Laboratories Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: EPS: ₹16.81 (vs ₹13.70 in 2Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Coral Laboratories Limited to Report Q2, 2024 Results on Nov 09, 2023

Coral Laboratories Limited to Report Q1, 2024 Results on Aug 12, 2023

Full year 2023 earnings released: EPS: ₹18.04 (vs ₹25.32 in FY 2022)

Coral Laboratories Limited, Annual General Meeting, Aug 11, 2023

New major risk - Market cap size

Full year 2023 earnings released: EPS: ₹18.04 (vs ₹25.32 in FY 2022)

Coral Laboratories Limited to Report Q4, 2023 Results on May 23, 2023

Third quarter 2023 earnings released: EPS: ₹2.40 (vs ₹0.69 in 3Q 2022)

Coral Laboratories Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: EPS: ₹13.70 (vs ₹1.26 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹13.70 (vs ₹1.26 in 2Q 2022)

Coral Laboratories Limited to Report Q2, 2023 Results on Nov 11, 2022

First quarter 2023 earnings released: EPS: ₹4.44 (vs ₹16.24 in 1Q 2022)

Coral Laboratories Limited, Annual General Meeting, Sep 29, 2022

Full year 2022 earnings released: EPS: ₹25.32 (vs ₹37.94 in FY 2021)

Coral Laboratories Limited to Report Q4, 2022 Results on May 27, 2022

Coral Laboratories Limited Receives Resignation of Sanket Mehta as Independent Director

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Coral Laboratories Limited to Report Q3, 2022 Results on Feb 11, 2022

Investor sentiment deteriorated over the past week

Non-Executive Director Purvi Doshi has left the company

Full year 2021 earnings released: EPS ₹37.94 (vs ₹19.96 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹12.95 (vs ₹6.30 in 3Q 2020)

Investor sentiment improved over the past week

Coral Laboratories Limited to Report Q3, 2021 Results on Feb 11, 2021

New 90-day low: ₹274

New 90-day low: ₹297

New 90-day low: ₹306

Market pulls back on stock over the past week

Coral Laboratories Limited to Report Q2, 2021 Results on Nov 12, 2020

New 90-day high: ₹392

New 90-day high - ₹322

First quarter earnings released

Coral Laboratories Limited to Report Q1, 2021 Results on Sep 04, 2020

Full year earnings released - EPS ₹19.96

New 90-day high - ₹286

New 90-day high - ₹233

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령